UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 197

Sortiert nach

Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies

Bone marrow transplantation (Basingstoke), 2007-09, Vol.40 (5), p.437-441

2007

Volltextzugriff (PDF)

Impact of the Affordable Care Act and Medicaid Expansion on Insurance Coverage and Outcomes in Patients with HIV‐associated Aggressive B‐cell Non‐Hodgkin Lymphomas

Hematological oncology, 2023-06, Vol.41 (S2), p.243-244

2023

Volltextzugriff (PDF)

Enteropathy-Type Intestinal T-Cell Lymphoma: Clinical Features and Treatment of 31 Patients in a Single Center

Journal of clinical oncology, 2000-02, Vol.18 (4), p.795-803

2000

Volltextzugriff (PDF)

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study

Annals of oncology, 2010-06, Vol.21 (6), p.1196-1202

2010

Volltextzugriff (PDF)

Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2012-04, Vol.47 (4), p.488-493

2012

Volltextzugriff (PDF)

Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen

Bone marrow transplantation (Basingstoke), 2007-08, Vol.40 (3), p.239-243

2007

Volltextzugriff (PDF)

Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab

Bone marrow transplantation (Basingstoke), 2011-02, Vol.46 (2), p.262-266

2011

Volltextzugriff (PDF)

Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia

Bone marrow transplantation (Basingstoke), 2012-02, Vol.47 (2), p.231-235

2012

Volltextzugriff (PDF)

Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2009-12, Vol.44 (11), p.767-768

2009

Volltextzugriff (PDF)

Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies

British journal of haematology, 2006-11, Vol.135 (3), p.374-381

2006

Volltextzugriff (PDF)

Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.84-89

2011

Volltextzugriff (PDF)

A UK multicentre phase II study of rituximab (chimaeric anti‐CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response

British journal of haematology, 2000-04, Vol.109 (1), p.81-88

2000

Volltextzugriff (PDF)

Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma

Bone marrow transplantation (Basingstoke), 2007-11, Vol.40 (10), p.973-978

2007

Volltextzugriff (PDF)

Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation

Journal of clinical oncology, 1996-09, Vol.14 (9), p.2465-2472

1996

Volltextzugriff (PDF)

Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation

Bone marrow transplantation (Basingstoke), 2011-12, Vol.46 (12), p.1519-1525

2011

Volltextzugriff (PDF)

Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa

European journal of cancer (1990), 2003-02, Vol.39 (3), p.335-345

2003

Volltextzugriff (PDF)

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?

British journal of cancer, 2004-04, Vol.90 (7), p.1302-1305

2004

Volltextzugriff (PDF)

Trials in advanced Hodgkin's disease: asking the right questions at the right time

British journal of cancer, 2001-05, Vol.84 (10), p.1291-1292

Sweetenham, J

2001

Volltextzugriff (PDF)

85 Differences in Emergency Department Use Among Cancer Patients Who Have Used an Oncology Urgent Care Clinic

Annals of emergency medicine, 2021-10, Vol.78 (4), p.S34-S34

2021

Volltextzugriff (PDF)

High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy : results from the EBMT

Bone marrow transplantation (Basingstoke), 1997-11, Vol.20 (9), p.745-752

1997

Volltextzugriff (PDF)

Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?

Bone marrow transplantation (Basingstoke), 2001-11, Vol.28 (9), p.813-820

SWEETENHAM, J. W

2001

Volltextzugriff (PDF)

Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility study

Bone marrow transplantation (Basingstoke), 2005-09, Vol.36 (5), p.443-451

2005

Volltextzugriff (PDF)

25 Factors Associated with Emergency Department Use among Adults with Newly Diagnosed Cancer

Annals of emergency medicine, 2020-10, Vol.76 (4), p.S10-S10

2020

Volltextzugriff (PDF)

Low‐dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue

British journal of haematology, 2007-06, Vol.137 (5), p.436-442

2007

Volltextzugriff (PDF)

High-Dose Therapy and Autologous Stem-Cell Transplantation for Adult Patients With Hodgkin's Disease Who Do Not Enter Remission After Induction Chemotherapy: Results in 175 Patients Reported to the European Group for Blood and Marrow Transplantation

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3101-3109

1999

Volltextzugriff (PDF)

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(165)

Publikationsform

Artikel
(161)
Buchkapitel
(19)
Reviews
(15)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(93)
Science & Technology
(86)
Life Sciences & Biomedicine
(85)
Biological And Medical Sciences
(63)
Oncology
(63)
Female
(62)
Adult
(60)
Medical Sciences
(60)
Male
(59)
Middle Aged
(58)
Aged
(49)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(37)
Hematology
(36)
Hematologic And Hematopoietic Diseases
(25)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(25)
Treatment Outcome
(25)
Adolescent
(24)
Chemotherapy
(23)
Prognosis
(21)
Antineoplastic Agents
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies

Impact of the Affordable Care Act and Medicaid Expansion on Insurance Coverage and Outcomes in Patients with HIV‐associated Aggressive B‐cell Non‐Hodgkin Lymphomas

Enteropathy-Type Intestinal T-Cell Lymphoma: Clinical Features and Treatment of 31 Patients in a Single Center

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study

Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation

Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen

Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab

Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia

Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation

Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies

Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT

A UK multicentre phase II study of rituximab (chimaeric anti‐CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response

Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma

Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation

Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation

Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?

Trials in advanced Hodgkin's disease: asking the right questions at the right time

85 Differences in Emergency Department Use Among Cancer Patients Who Have Used an Oncology Urgent Care Clinic

High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy : results from the EBMT

Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?

Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility study

25 Factors Associated with Emergency Department Use among Adults with Newly Diagnosed Cancer

Low‐dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue

High-Dose Therapy and Autologous Stem-Cell Transplantation for Adult Patients With Hodgkin's Disease Who Do Not Enter Remission After Induction Chemotherapy: Results in 175 Patients Reported to the European Group for Blood and Marrow Transplantation

Suchergebnisse filtern